Opioid use

Vaping and Opioid Addiction Accelerate Coronavirus Risks

The coronavirus pandemic has presented a new challenge for public health services around the world. Although scientists are working tirelessly to comprehend more about the virus, there are still many unanswered questions. In a recent interview, Dr. Nora Volkow, who heads the National Institute on Drug Abuse, describes factors that may increase the risk of coronavirus causing greater harm to the infected individual. Read the full interview here.

Opioid Use May Increase Risk of Dangerous Heart Rhythm Disorder

Publication Date

Abuse of opioids can lead to many adverse consequences including addiction and heightened risk of overdose, however it is being increasingly suggested that even controlled use of prescription opioids may be linked with serious and enduring side effects. There is mounting evidence that suggests opioid use may contribute towards cardiovascular damage.

The Intersection of Opioids and Suicide: A Prevention Approach

Webinar,

The latest event from the National Prevention Week Webinar Series will take place on October 25, 2018, 2:00 – 3:30 p.m. EDT. 

The discussion will explore the relationship between the opioid use, overdose and suicide, with the hope that it will create opportunities for those in the prevention field to implement more effective strategies.

National Prevention Week 2018

National Prevention week led by the Substance Abuse and Mental Health Administration (SAMHSA) will take place from 13-19th May 2018. Each day focus will fall on a different topic - starting off with the theme of "Promotion of Mental Health and Wellness" on Monday. Themes for the rest of the week are: Prevention of Underage Drinking and Alcohol Misuse on Tuesday; Prevention of Prescription and Opioid Drug Misuse on Wednesday; Prevention of Illicit Drug Use

Systemic and Individual Factors in the Buprenorphine Treatment-Seeking Process: A Qualitative Study

Citation
Hewell V, Vasquez A, Rivkin I. (2017). Substance Abuse Treatment, Prevention, and Policy 12: 3 DOI 10.1186/s13011-016-0085-y
Publication Date

Abstract

Background: Opioid use is a significant problem in Alaska. Medication-assisted treatment for opioid use, including buprenorphine, reduces withdrawal symptoms and the harm associated with opioid abuse. Understanding consumers’ treatment-seeking process is important for addressing barriers to treatment, facilitating effective service utilization, and informing policy.